Correlation Between Terns Pharmaceuticals and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both Terns Pharmaceuticals and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Terns Pharmaceuticals and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Terns Pharmaceuticals and Larimar Therapeutics, you can compare the effects of market volatilities on Terns Pharmaceuticals and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Terns Pharmaceuticals with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Terns Pharmaceuticals and Larimar Therapeutics.
Diversification Opportunities for Terns Pharmaceuticals and Larimar Therapeutics
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Terns and Larimar is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Terns Pharmaceuticals and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and Terns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Terns Pharmaceuticals are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of Terns Pharmaceuticals i.e., Terns Pharmaceuticals and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between Terns Pharmaceuticals and Larimar Therapeutics
Given the investment horizon of 90 days Terns Pharmaceuticals is expected to under-perform the Larimar Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Terns Pharmaceuticals is 1.07 times less risky than Larimar Therapeutics. The stock trades about 0.0 of its potential returns per unit of risk. The Larimar Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 534.00 in Larimar Therapeutics on October 25, 2024 and sell it today you would lose (181.50) from holding Larimar Therapeutics or give up 33.99% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Terns Pharmaceuticals vs. Larimar Therapeutics
Performance |
| Timeline |
| Terns Pharmaceuticals |
| Larimar Therapeutics |
Terns Pharmaceuticals and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Terns Pharmaceuticals and Larimar Therapeutics
The main advantage of trading using opposite Terns Pharmaceuticals and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Terns Pharmaceuticals position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| Terns Pharmaceuticals vs. X4 Pharmaceuticals | Terns Pharmaceuticals vs. Day One Biopharmaceuticals | Terns Pharmaceuticals vs. Hookipa Pharma | Terns Pharmaceuticals vs. Amylyx Pharmaceuticals |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |